tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
BCRX is currently covered by 11 analysts with an average price target of $19.52. This is a potential upside of $10.09 (98.58%) from yesterday's end of day stock price of $9.83.
BioCryst Pharmaceuticals's activity chart (see below) currently has 172 price targets and 168 ratings on display. The stock rating distribution of BCRX is 90% BUY and 10% HOLD.
Analysts average stock forecasts to be materialized ratio is 46.01% with an average time for these price targets to be met of 267 days.
Highest price target for BCRX is $32, Lowest price target is $8, average price target is $19.52.
Most recent stock forecast was given by LAURA CHICO from WEDBUSH on 06-Aug-2026. First documented stock forecast 18-Feb-2014.
Currently out of the existing stock ratings of BCRX, 18 are a BUY (90%), 2 are a HOLD (10%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 30-Jun-2025
$20
$10.45 (109.42%)
$21
Buy Since 25-Sep-2023
$13
$3.45 (36.13%)
$14
Hold Since 13-Jul-2026
$12
$2.45 (25.65%)
$13
Buy Since 29-Apr-2025
$29
$19.45 (203.66%)
$26
Buy Since 26-Jun-2020
$28
$18.06 (181.69%)
$27
What is BCRX (BioCryst Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on BCRX (BioCryst Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on BCRX (BioCryst Pharmaceuticals)?
Which analyst is the currently most bullish on BCRX (BioCryst Pharmaceuticals)?
Which analyst is the currently most reserved on BCRX (BioCryst Pharmaceuticals)?
